This Week Last Year in Medtech: May 14-20

See what Medtronic, Labcorp, and Stryker were up to this time last year.

Katie Hobbins, Managing Editor

May 18, 2023

2 Min Read
Calendar pages
Archive Holdings Inc. / The Image Bank via Getty Images

Medtronic Wins FDA Nod for Onyx Frontier DES

The Dublin-based company said the device is the latest innovation in the Resolute DES family.

Babson Has Friends in High Places

The blood-testing startup that's trying to succeed where Theranos failed has expanded its strategic partnership with the sixth largest medtech company in the world.

MannKind Acquires Wearable Insulin Device from Zealand Pharma

The Danbury, CT-based company said it was picking up the V-Go wearable $10 million.

An At-Home Collection Device for Diabetes Risk Testing

Labcorp and Weavr teamed up for the development of the at-home-collection device.

Medtronic Wants to Ease Your Pain with Closed-Loop Implantable

A prospective study will evaluate the long-term performance of a closed-loop algorithm with Medtronic’s investigative rechargeable neurostimulator.

Stryker Is Smart to Pursue This Type of Reimbursement

CMS recently established a new code for outpatient hospitals and ambulatory surgery centers to report the insertion of Stryker's InSpace balloon implant.

Medtronic Touts Cusp Overlap Technique in TAVR

Mid-term results of the Optimize PRO clinical study underscores predictability and control using the cusp overlap technique during transcatheter aortic valve replacement (TAVR) with Medtronic TAVR devices.

The Robot Will Do Your Angioplasty Now

Study results show promise for robotic coronary angioplasties using Robocath's R-One robot.

J&J MedTech Lands Clearance for Inhance Shoulder System

This clearance is in addition to the system’s already cleared use in anatomic shoulder arthroplasty.

Abbott Heart Valve Data Shines at EuroPCR

The data support the use of the company's TriClip tricuspid heart valve repair device, and Navitor, Abbott's transcatheter aortic valve implantation system.

NeuroOne’s Bid for Long-term Use of Evo sEEG Shot Down by FDA

The Eden Praire, MN-based company called the decision disappointing but said it would collect more data and submit for a Special 510 (k).

Has Medtech Shifted to a Seller's Strike?

Analyst says both the number and dollar volume of medtech M&A deals are likely to drop in 2022, compared to 2021.

About the Author

Katie Hobbins

Managing Editor, MD+DI

Katie Hobbins is managing editor for MD+DI and joined the team in July 2022. She boasts multiple previous editorial roles in print and multimedia medical journalism, including dermatology, medical aesthetics, and pediatric medicine. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and anything DIY. You can reach her at [email protected].

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like